IL18 and COVID-19: Therefore, to investigate whether loss of IL-18 negative feedback control is associated with life-threatening disease in COVID-19, we designed an observational, prospective cohort study looking at IL-18 negative feedback control from symptom day 15 onwards, in hospitalised patients testing positive with COVID-19.